$304.67 0.2%
Price vs. AI Score (Last 150 days)
Data gathered: November 29

Data Bits

Data Bits Value / Change Benchmark
Job Posts 196 4.3%
Sentiment 72 7.5%
Webpage traffic 520,000 -5.2%
Employee Rating 69 0%
Google Adspend $12,959 -19.6% N/A
Google Trends 52 67.7%
Linkedin Employees 8,532 N/A
Patents 455 0%
4chan Mentions 0%
Facebook Engagement 287 -7.4%
Facebook followers 9,222 0.1%
Stocktwits Mentions 1 0%
Stocktwits Subscribers 927 0.1%
Twitter Followers 17,335 0%
Instagram Followers 10,417 0%
News Mentions 0%
Reddit Mentions 0%
Business outlook 58 0%

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

In the news

About Bio-Rad

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the following segments: Life Sciences and Clinical Diagnostics. The Life Science segment develops, manufactures and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells and supports test systems, informatics systems, test kits and specialize in quality controls that serve clinical laboratories in the global diagnostics market.

Price $304.67
Target Price Sign up
Market Cap $8.92B
Dividend Yield 0.0171
Industry Biotechnology

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda
Q3 '23621M504M336M106M156M
Q2 '23669M532M362M-1.16B-1.48B
Q1 '23666M582M362M69M139M
Q4 '22730M475M397M828M1.01B
Q3 '22666M524M373M-163M-190M

Insider Transactions

Crowley Michael filed to sell 6,942 shares at $305.1.
November 28 '23
ERNST TIMOTHY S filed to sell 2,416 shares at $396.4.
August 31 '23
ERNST TIMOTHY S filed to sell 2,416 shares at $384.7.
August 23 '23
Crowley Michael filed to sell 6,040 shares at $379.4.
June 16 '23
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2023 AltIndex. All rights reserved.